
Globus Medical GMED
$ 90.52
0.17%
Annual report 2025
added 02-24-2026
Globus Medical Interest Expense 2011-2026 | GMED
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Globus Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.41 M | 2.2 M | -2.14 M | 1.86 M | 8.45 M | 14.5 M | 18 M | 19.3 M | 8.09 M | 3.14 M | 583 K | 280 K | 328 K | -140 K | -413 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 19.3 M | -2.14 M | 5.16 M |
Quarterly Interest Expense Globus Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.54 M | 772 K | 713 K | -570 K | 997 K | 710 K | -475 K | 8.46 M | 6.79 M | - | 1.76 M | 2.76 M | 2.45 M | - | 1.12 M | 3.06 M | 2.65 M | - | 3.12 M | 3.62 M | 4.05 M | - | 4.69 M | 4.22 M | 4.57 M | - | 4.3 M | 8.16 M | 2.44 M | - | 1.56 M | 2.19 M | 2.1 M | - | 1.2 M | 418 K | 760 K | - | 253 K | 441 K | -347 K | - | -124 K | 325 K | 245 K | - | 197 K | -221 K | 279 K | - | -45 K | -304 K | 225 K | - | -172 K | -25 K | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.46 M | -570 K | 1.84 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
45.9 M | $ 10.89 | -0.11 % | $ 1.63 B | ||
|
AxoGen
AXGN
|
167 K | $ 31.98 | 0.06 % | $ 1.47 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 173.12 | -0.01 % | $ 13 B | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 12.5 | 2.71 % | $ 1.69 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 282.0 | 1.03 % | $ 7.96 B | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.33 | 0.91 % | $ 125 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 37.77 | 0.48 % | $ 5.63 K | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 61.78 | 0.03 % | $ 91.5 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 8.7 | 0.25 % | $ 246 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
78 K | $ 24.12 | - | $ 204 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.86 | -1.59 % | $ 1.13 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Inogen
INGN
|
2.44 M | $ 6.34 | 0.16 % | $ 169 M | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 15.89 | -0.5 % | $ 373 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 62.12 | -1.05 % | $ 3.39 B | ||
|
LENSAR
LNSR
|
636 K | $ 5.59 | -1.93 % | $ 66.8 M | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.13 | 0.61 % | $ 874 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
-70 K | $ 10.4 | 3.59 % | $ 373 M | ||
|
Myomo
MYO
|
-668 K | $ 0.69 | 0.51 % | $ 28.9 M | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 53.9 | -0.19 % | $ 1.58 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 36.26 | -1.31 % | $ 1.13 B | ||
|
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 84.8 | -0.4 % | $ 2.95 B | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.65 | -0.16 % | $ 122 M |